APH trades 11.5% below Wall Street's consensus target of $182.89.
Last 12 months price action with 12-month analyst target path
The base valuation assumes APH achieves its forward estimates and maintains a stable P/E multiple of 34.2x. This scenario reflects the blended consensus of 29 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of June 22, 2026, Amphenol Corporation (APH) has a Wall Street consensus price target of $182.89, based on estimates from 29 covering analysts. With the stock currently trading at $163.96, this represents a potential upside of +11.5%. The company has a market capitalization of $201.58B.
Analyst price targets range from a low of $165.00 to a high of $215.00, representing a 27% spread in expectations. The median target of $178.00 aligns closely with the consensus average.
The current analyst consensus rating is Buy, with 15 analysts rating the stock as a Buy or Strong Buy,13 rating it Hold, and 1 rating it Sell or Strong Sell. The positive sentiment balance indicates moderate optimism about the stock prospects.
From a valuation perspective, APH trades at a trailing P/E of 49.1x and forward P/E of 34.2x. The forward PEG ratio of 1.23 indicates reasonable valuation for growth. Analysts expect EPS to grow +38.0% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $212.84, with bear and bull scenarios of $134.09 and $280.44 respectively. Model confidence stands at 55/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
TELTE Connectivity Ltd. | $63.9B | $217.64 | $262.29 | +20.5% | Buy | 19.4x | 29 |
HUBBHubbell Incorporated | $27.8B | $523.69 | $551.33 | +5.3% | Hold | 26.5x | 17 |
BDCBelden Inc. | $4.8B | $123.26 | $152.50 | +23.7% | Buy | 15.4x | 14 |
CNXCConcentrix Corporation | $1.8B | $25.08 | $52.00 | +107.3% | Buy | 2.1x | 9 |
GLWCorning Incorporated | $167.5B | $195.00 | $169.11 | -13.3% | Buy | 61.2x | 37 |
ROGRogers Corporation | $2.9B | $162.68 | $150.00 | -7.8% | Buy | 44.7x | 12 |
VICRVicor Corporation | $14.9B | $331.37 | $297.50 | -10.2% | Buy | 111.5x | 7 |
TTMITTM Technologies, Inc. | $22.5B | $216.44 | $209.33 | -3.3% | Buy | 53.4x | 14 |
CTSCTS Corporation | $1.9B | $67.00 | — | — | Hold | 27.6x | 4 |
KFRCKforce Inc. | $830M | $45.39 | $71.00 | +56.4% | Hold | 18.9x | 10 |
Quick answers to the most common questions about buying APH stock.
Amphenol Corporation (APH) has a consensus 12-month price target of $182.89, implying 11.5% upside from $163.96. The 29 analysts covering APH see moderate appreciation potential.
APH has a consensus rating of "Buy" based on 29 Wall Street analysts. The rating breakdown is predominantly bullish, with 15 Buy/Strong Buy ratings. The consensus 12-month price target of $182.89 implies 11.5% upside from current levels.
APH trades at a forward P/E of 34.2382x, representing a moderate valuation. With analysts targeting $182.89 (11.5% implied move), the stock appears reasonably valued with upside.
The most bullish Wall Street analyst has a price target of $215 for APH, while the most conservative target is $165. The consensus of $182.89 represents the median expectation. Our quantitative valuation model projects a bull case target of $280 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
APH is heavily covered by Wall Street, with 29 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 15 have Buy ratings, 13 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month APH stock forecast based on 29 Wall Street analysts shows a consensus price target of $182.89, with estimates ranging from $165 (bear case) to $215 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $213, with bear/bull scenarios of $134/$280.
Our quantitative valuation model calculates APH's fair value at $213 (base case), with a bear case of $134 and bull case of $280. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 55/100.
APH trades at a forward P/E ratio of 34.2x based on next-twelve-months earnings estimates compared to a trailing P/E of 49.1x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Wall Street analysts are optimistic on APH, with a "Buy" consensus rating and $182.89 price target (11.5% upside). 15 of 29 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
APH analyst price targets range from $165 to $215, a 27% moderate spread showing some variance in outlooks. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $182.89 consensus represents the middle ground. Our model's $134-$280 range provides an independent fundamental perspective.
Deep dive into APH consensus models and risk factors.
Wall Street verdict, signals, and target summaries.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.